140 related articles for article (PubMed ID: 27766386)
1. [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].
Schilimow A; Wiechens B
Ophthalmologe; 2017 Aug; 114(8):745-747. PubMed ID: 27766386
[TBL] [Abstract][Full Text] [Related]
2. Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.
Fuchsluger T; Tuerkeli E; Westekemper H; Esser J; Steuhl KP; Meller D
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):955-64. PubMed ID: 17219124
[TBL] [Abstract][Full Text] [Related]
3. [Protective ptosis by botulinum A toxin injection in corneal affectations].
Gusek-Schneider GC; Erbguth F
Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
[TBL] [Abstract][Full Text] [Related]
4. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
Reddy UP; Woodward JA
Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
[TBL] [Abstract][Full Text] [Related]
5. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
Ellis MF; Daniell M
Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
[TBL] [Abstract][Full Text] [Related]
7. Temporary tarsorrhaphy induced with type A botulinum toxin.
Wuebbolt GE; Drummond G
Can J Ophthalmol; 1991 Dec; 26(7):383-5. PubMed ID: 1764645
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin injection for production of ptosis].
Merté RL; Lanzl IM
Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
Steinsapir KD; Groth MJ; Boxrud CA
Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
Yücel OE; Artürk N
Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
[TBL] [Abstract][Full Text] [Related]
11. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
[TBL] [Abstract][Full Text] [Related]
12. [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].
Ferreira de Souza R; Kruse FE; Seitz B
Klin Monbl Augenheilkd; 2001 Nov; 218(11):720-6. PubMed ID: 11731899
[TBL] [Abstract][Full Text] [Related]
13. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic keratopathy.
Dua HS; Said DG; Messmer EM; Rolando M; Benitez-Del-Castillo JM; Hossain PN; Shortt AJ; Geerling G; Nubile M; Figueiredo FC; Rauz S; Mastropasqua L; Rama P; Baudouin C
Prog Retin Eye Res; 2018 Sep; 66():107-131. PubMed ID: 29698813
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis, clinical features and management of recurrent corneal erosions.
Ramamurthi S; Rahman MQ; Dutton GN; Ramaesh K
Eye (Lond); 2006 Jun; 20(6):635-44. PubMed ID: 16021185
[TBL] [Abstract][Full Text] [Related]
16. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
Ling JD; Gire A; Pflugfelder SC
Am J Ophthalmol; 2013 Apr; 155(4):615-619, 619.e1-2. PubMed ID: 23218704
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options for the management of early neurotrophic keratopathy: a case report and review.
Reynolds SA; Kabat AG
Optometry; 2006 Oct; 77(10):503-7. PubMed ID: 17000411
[TBL] [Abstract][Full Text] [Related]
18. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
Sadiq SA; Dharmasena A
Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
[TBL] [Abstract][Full Text] [Related]
19. The changes in corneal astigmatism after botulinum toxin-a injection in patients with blepharospasm.
Moon NJ; Lee HI; Kim JC
J Korean Med Sci; 2006 Feb; 21(1):131-5. PubMed ID: 16479079
[TBL] [Abstract][Full Text] [Related]
20. [Persistent corneal defects treated with botulinum toxin-induced ptosis].
Vleming EN; Pérez-Rico C; Montes MA; Pareja J
Arch Soc Esp Oftalmol; 2007 Sep; 82(9):547-50. PubMed ID: 17846944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
